Fountainhead AM’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Fountainhead AM’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-29,928	Closed	-$21K	–	63
2020 Q4	$21K	Buy	+29,928	New	+$63.7K	0.01%	53

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Fountainhead AM's BMY.RT Position: Q1 2021 in Review

Fountainhead AM sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 29,928 shares — an estimated $21K sold.

Fountainhead AM first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $21K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Fountainhead AM reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Fountainhead AM sold 29,928 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $21K.
Fountainhead AM first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
Fountainhead AM's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $21K in Q4 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Fountainhead AM's 13F filing for Q1 2021, filed 6 May 2021.